IMMUNOMEDICS INC 4/A

4/A · IMMUNOMEDICS INC · Filed Dec 14, 2015

Form 4/AAmended

Period: 2015-12-01

Director

Transactions

Award
Stock Options (right to buy)
2015-12-02+28,821→ 28,821 total
Exercise: $3.11Exp: 2022-12-02→ Common Stock, par value $0.01 per share (28,821 underlying)
Award
Restricted Stock Units
2015-12-02+14,469→ 14,469 total
→ Common Stock, par value $0.01 per share (14,469 underlying)
Sale
Common Stock
2015-12-01$3.15/sh−5,100$16,090→ 45,350 total
Exercise/Conversion
Common Stock
2015-12-01$1.59/sh+10,000$15,900→ 50,450 total
Exercise/Conversion
Common Stock
2015-12-01+10,664→ 56,014 total
Tax Payment
Common Stock
2015-12-01−4,266→ 51,748 total
Exercise/Conversion
Stock Options (right to buy)
2015-12-01−10,000→ 0 total
Exercise: $1.59Exp: 2015-12-03→ Common Stock, par value $0.01 per share (10,000 underlying)
Exercise/Conversion
Restricted Stock Units
2015-12-01−10,664→ 0 total
→ Common Stock, par value $0.01 per share (10,664 underlying)

Footnotes (5)

[F1]Delivery of common stock upon vesting of restricted stock units granted on December 3, 2014.
[F2]The purpose of this amendment is to correct the number of shares withheld to satisfy the tax withholding obligation of the reporting person reported in the Form 4 filed on December 4, 2015.
[F3]The number of shares withheld to satisfy the tax withholding obligation of the reporting person upon vesting of Restricted Stock Units is correlated with the reporting person's tax withholding percentage.
[F4]The stock options are fully vested on the date of grant.
[F5]Each restricted stock unit represents a contingent right to receive one share of Immunomedics, Inc. common stock. The restricted stock units shall vest upon the earlier of (i) the reporting person's completion of one year of service as a non-employee director from the date of grant, or (ii) the reporting person's continuation in service through the day immediately preceding the next annual stockholders meeting following the date of grant.

Documents

1 file